| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.74B | — |
| Operating expense | — | — |
| Net income | 97.50M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BIIB returned +55.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +23.2% |
| 1 year | +55.6% |
| 5 years | -36.0% |
| 10 years | -29.1% |
| All-time high | $422.24 (Mar 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BIIB would be worth today ›No. Biogen Inc. has not paid a dividend in the past 12 months.
Biogen Inc. stock trades on NASDAQ under the ticker symbol BIIB.
Biogen Inc. is part of the Healthcare sector.
Biogen Inc. has a market cap of 32.03B USD, based on the latest quote.
Biogen Inc. is scheduled to report earnings on Oct 29, 2026.
